Sudden deaths following influenza vaccination: Can this be expected?

Autor: van der Sande, M.A.B., van Asten, L., Straus, S.M.J.M., Schim van der Loeff, M.F., Wallinga, J., Conyn-van Spaendonck, M.A.E.

Publikováno v: In Vaccine 2008 26(3):379-382

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Long-term use of 5α-reductase inhibitors and the risk of male breast cancer

Autor: Duijnhoven, R.G., Straus, S.M.J.M., Souverein, P.C., de Boer, A., Bosch, J.L.H.R., Hoes, A.W., De Bruin, M.L., Sub Pharmacoepidemiology, Dep Farmaceutische wetenschappen, Sub Pharmacotherapy, Theoretical

Publikováno v: Cancer Causes & Control, 25(11), 1577-1582. Springer Netherlands
Cancer Causes & Control, 25(11), 1577
Cancer Causes and Control, 25(11), 1577-1582. Springer Netherlands

Methods: A case–control study was conducted with data from the United Kingdom Clinical Practice Research Datalink database among all men aged 45 years and older in the period 1 January 1992 to 31 December 2011. Cases of men diagnosed with breast ca

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e6d2167d571f2445c89598b65ef717c
https://doi.org/10.1007/s10552-014-0455-6

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Number of Patients Studied Prior to Approval of New Medicines: A Database Analysis

Autor: Duijnhoven, R.G., Straus, S.M.J.M., Raine, J.M., de Boer, A., Hoes, A.W., De Bruin, M.L., Pharmacoepidemiology, Pharmacoepidemiology and Clinical Pharmacology, Population-based studies of drug treatment: from molecule to patient outcomes, Sub Pharmacoepidemiology, Sub Pharmacotherapy, Theoretical, Sub Algemeen Bureau

Publikováno v: PLoS Medicine, 10(3), e1001407/1. Nature Publishing Group
PLoS Medicine
PLoS Medicine (print), 10(3). Public Library of Science
PLoS Medicine, Vol 10, Iss 3, p e1001407 (2013)

In an evaluation of medicines approved by the European Medicines Agency 2000 to 2010, Ruben Duijnhoven and colleagues find that the number of patients evaluated for medicines approved for chronic use are inadequate for evaluation of safety or long-te

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cfc731d2bdca239a18cdde22d8648ff
https://dspace.library.uu.nl/handle/1874/308996